By Index  >  FTSE Aim 100  >  GW Pharmaceuticals plc

GW Pharmaceuticals plc

Company Overview

GW Pharmaceuticals is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of non-smoked prescription medicines derived from cannabis, including Sativex®, to meet patient needs in a wide range of therapeutic indications. The Group has also expanded its research to include the use of other controlled drugs in conjunction with its proprietary secure drug dispensing technology.

Annual Reports
Description		Report Date	Published	Current
	Annual Report 2009 in PDF	30/09/2009	24/11/2009	Yes
	Annual Report 2008 in PDF	30/09/2008	17/11/2008	No
	Annual Report 2007 in PDF	30/09/2007	21/01/2008	No

Interim Reports
Description		Report Date	Published	Current
	Interim Results 2009 in PDF	31/03/2009	20/05/2009	Yes
	Interim Results 2008 in PDF	31/03/2008	18/06/2008	No

Other Links
Description
	Home
	Site Map
	Events Calendar
	Results Index
	Press Releases
	Presentations
	Contacts